nifedipine has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chiu, LY | 1 |
| Ko, JL | 1 |
| Lee, YJ | 1 |
| Yang, TY | 1 |
| Tee, YT | 1 |
| Sheu, GT | 1 |
1 other study available for nifedipine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines.
Topics: ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member | 2010 |